The pharmaceutical company in a statement on Monday (Nov 15) said that in Myanmar, the Sinovac Covid-19 vaccine will be marketed by Hemas Mandalar Pharmaceuticals Ltd, a Myanmar-based pharmaceutical company, which has placed an initial order of 200,000 doses of filled and finished Sinovac Covid-19 vaccine from Pharmaniaga. Pharmaniaga group managing director Datuk Zulkarnain Md Eusope said the collaboration with Hemas Mandalar would help to accelerate Myanmar’s private market vaccination programme. Follow our Covid-19 vaccination tracker to see where we are in the race to herd immunity. "We are pleased and grateful to have successfully delivered our first international delivery as well as our first batch of filled and finished Sinovac Covid-19 vaccine to Hemas Mandalar. Zulkarnain noted the export of Sinovac Covid-19 vaccines gives confidence to Pharmaniaga to further explore similar opportunities in other Southeast Asia neighbouring countries and also the African countries.

Source: The Edge Markets November 15, 2021 16:12 UTC